Request for Covid-19 Impact Assessment of this Report

Healthcare

Global Bacille Calmette-Guerin Vaccine Market Growth 2022-2028

  • LP 4962080
  • 95 Pages
  • June 2022
  • Healthcare
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Bacille Calmette-Guerin Vaccine will have significant change from previous year. According to our (LP Information) latest study, the global Bacille Calmette-Guerin Vaccine market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Bacille Calmette-Guerin Vaccine market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.

The United States Bacille Calmette-Guerin Vaccine market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Bacille Calmette-Guerin Vaccine market, reaching US$ million by the year 2028. As for the Europe Bacille Calmette-Guerin Vaccine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.

Global main Bacille Calmette-Guerin Vaccine players cover Merck, Sanofi Pasteur, Japan BCG Lab, and China National Biotec, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Bacille Calmette-Guerin Vaccine market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Immune

Therapy

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Private Distribution Channel

Public Distribution Channel

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Merck

Sanofi Pasteur

Japan BCG Lab

China National Biotec

Serum Institute of India

Intervax

GSBPL

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Bacille Calmette-Guerin Vaccine Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Bacille Calmette-Guerin Vaccine by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Bacille Calmette-Guerin Vaccine by Country/Region, 2017, 2022 & 2028

2.2 Bacille Calmette-Guerin Vaccine Segment by Type

2.2.1 Immune

2.2.2 Therapy

2.3 Bacille Calmette-Guerin Vaccine Sales by Type

2.3.1 Global Bacille Calmette-Guerin Vaccine Sales Market Share by Type (2017-2022)

2.3.2 Global Bacille Calmette-Guerin Vaccine Revenue and Market Share by Type (2017-2022)

2.3.3 Global Bacille Calmette-Guerin Vaccine Sale Price by Type (2017-2022)

2.4 Bacille Calmette-Guerin Vaccine Segment by Application

2.4.1 Private Distribution Channel

2.4.2 Public Distribution Channel

2.5 Bacille Calmette-Guerin Vaccine Sales by Application

2.5.1 Global Bacille Calmette-Guerin Vaccine Sale Market Share by Application (2017-2022)

2.5.2 Global Bacille Calmette-Guerin Vaccine Revenue and Market Share by Application (2017-2022)

2.5.3 Global Bacille Calmette-Guerin Vaccine Sale Price by Application (2017-2022)

3 Global Bacille Calmette-Guerin Vaccine by Company

3.1 Global Bacille Calmette-Guerin Vaccine Breakdown Data by Company

3.1.1 Global Bacille Calmette-Guerin Vaccine Annual Sales by Company (2020-2022)

3.1.2 Global Bacille Calmette-Guerin Vaccine Sales Market Share by Company (2020-2022)

3.2 Global Bacille Calmette-Guerin Vaccine Annual Revenue by Company (2020-2022)

3.2.1 Global Bacille Calmette-Guerin Vaccine Revenue by Company (2020-2022)

3.2.2 Global Bacille Calmette-Guerin Vaccine Revenue Market Share by Company (2020-2022)

3.3 Global Bacille Calmette-Guerin Vaccine Sale Price by Company

3.4 Key Manufacturers Bacille Calmette-Guerin Vaccine Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Bacille Calmette-Guerin Vaccine Product Location Distribution

3.4.2 Players Bacille Calmette-Guerin Vaccine Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Bacille Calmette-Guerin Vaccine by Geographic Region

4.1 World Historic Bacille Calmette-Guerin Vaccine Market Size by Geographic Region (2017-2022)

4.1.1 Global Bacille Calmette-Guerin Vaccine Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Bacille Calmette-Guerin Vaccine Annual Revenue by Geographic Region

4.2 World Historic Bacille Calmette-Guerin Vaccine Market Size by Country/Region (2017-2022)

4.2.1 Global Bacille Calmette-Guerin Vaccine Annual Sales by Country/Region (2017-2022)

4.2.2 Global Bacille Calmette-Guerin Vaccine Annual Revenue by Country/Region

4.3 Americas Bacille Calmette-Guerin Vaccine Sales Growth

4.4 APAC Bacille Calmette-Guerin Vaccine Sales Growth

4.5 Europe Bacille Calmette-Guerin Vaccine Sales Growth

4.6 Middle East & Africa Bacille Calmette-Guerin Vaccine Sales Growth

5 Americas

5.1 Americas Bacille Calmette-Guerin Vaccine Sales by Country

5.1.1 Americas Bacille Calmette-Guerin Vaccine Sales by Country (2017-2022)

5.1.2 Americas Bacille Calmette-Guerin Vaccine Revenue by Country (2017-2022)

5.2 Americas Bacille Calmette-Guerin Vaccine Sales by Type

5.3 Americas Bacille Calmette-Guerin Vaccine Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Bacille Calmette-Guerin Vaccine Sales by Region

6.1.1 APAC Bacille Calmette-Guerin Vaccine Sales by Region (2017-2022)

6.1.2 APAC Bacille Calmette-Guerin Vaccine Revenue by Region (2017-2022)

6.2 APAC Bacille Calmette-Guerin Vaccine Sales by Type

6.3 APAC Bacille Calmette-Guerin Vaccine Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Bacille Calmette-Guerin Vaccine by Country

7.1.1 Europe Bacille Calmette-Guerin Vaccine Sales by Country (2017-2022)

7.1.2 Europe Bacille Calmette-Guerin Vaccine Revenue by Country (2017-2022)

7.2 Europe Bacille Calmette-Guerin Vaccine Sales by Type

7.3 Europe Bacille Calmette-Guerin Vaccine Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Bacille Calmette-Guerin Vaccine by Country

8.1.1 Middle East & Africa Bacille Calmette-Guerin Vaccine Sales by Country (2017-2022)

8.1.2 Middle East & Africa Bacille Calmette-Guerin Vaccine Revenue by Country (2017-2022)

8.2 Middle East & Africa Bacille Calmette-Guerin Vaccine Sales by Type

8.3 Middle East & Africa Bacille Calmette-Guerin Vaccine Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Bacille Calmette-Guerin Vaccine

10.3 Manufacturing Process Analysis of Bacille Calmette-Guerin Vaccine

10.4 Industry Chain Structure of Bacille Calmette-Guerin Vaccine

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Bacille Calmette-Guerin Vaccine Distributors

11.3 Bacille Calmette-Guerin Vaccine Customer

12 World Forecast Review for Bacille Calmette-Guerin Vaccine by Geographic Region

12.1 Global Bacille Calmette-Guerin Vaccine Market Size Forecast by Region

12.1.1 Global Bacille Calmette-Guerin Vaccine Forecast by Region (2023-2028)

12.1.2 Global Bacille Calmette-Guerin Vaccine Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Bacille Calmette-Guerin Vaccine Forecast by Type

12.7 Global Bacille Calmette-Guerin Vaccine Forecast by Application

13 Key Players Analysis

13.1 Merck

13.1.1 Merck Company Information

13.1.2 Merck Bacille Calmette-Guerin Vaccine Product Offered

13.1.3 Merck Bacille Calmette-Guerin Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Merck Main Business Overview

13.1.5 Merck Latest Developments

13.2 Sanofi Pasteur

13.2.1 Sanofi Pasteur Company Information

13.2.2 Sanofi Pasteur Bacille Calmette-Guerin Vaccine Product Offered

13.2.3 Sanofi Pasteur Bacille Calmette-Guerin Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Sanofi Pasteur Main Business Overview

13.2.5 Sanofi Pasteur Latest Developments

13.3 Japan BCG Lab

13.3.1 Japan BCG Lab Company Information

13.3.2 Japan BCG Lab Bacille Calmette-Guerin Vaccine Product Offered

13.3.3 Japan BCG Lab Bacille Calmette-Guerin Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Japan BCG Lab Main Business Overview

13.3.5 Japan BCG Lab Latest Developments

13.4 China National Biotec

13.4.1 China National Biotec Company Information

13.4.2 China National Biotec Bacille Calmette-Guerin Vaccine Product Offered

13.4.3 China National Biotec Bacille Calmette-Guerin Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 China National Biotec Main Business Overview

13.4.5 China National Biotec Latest Developments

13.5 Serum Institute of India

13.5.1 Serum Institute of India Company Information

13.5.2 Serum Institute of India Bacille Calmette-Guerin Vaccine Product Offered

13.5.3 Serum Institute of India Bacille Calmette-Guerin Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Serum Institute of India Main Business Overview

13.5.5 Serum Institute of India Latest Developments

13.6 Intervax

13.6.1 Intervax Company Information

13.6.2 Intervax Bacille Calmette-Guerin Vaccine Product Offered

13.6.3 Intervax Bacille Calmette-Guerin Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Intervax Main Business Overview

13.6.5 Intervax Latest Developments

13.7 GSBPL

13.7.1 GSBPL Company Information

13.7.2 GSBPL Bacille Calmette-Guerin Vaccine Product Offered

13.7.3 GSBPL Bacille Calmette-Guerin Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 GSBPL Main Business Overview

13.7.5 GSBPL Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Bacille Calmette-Guerin Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Bacille Calmette-Guerin Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Immune

Table 4. Major Players of Therapy

Table 5. Global Bacille Calmette-Guerin Vaccine Sales by Type (2017-2022) & (Units)

Table 6. Global Bacille Calmette-Guerin Vaccine Sales Market Share by Type (2017-2022)

Table 7. Global Bacille Calmette-Guerin Vaccine Revenue by Type (2017-2022) & ($ million)

Table 8. Global Bacille Calmette-Guerin Vaccine Revenue Market Share by Type (2017-2022)

Table 9. Global Bacille Calmette-Guerin Vaccine Sale Price by Type (2017-2022) & (US$/Unit)

Table 10. Global Bacille Calmette-Guerin Vaccine Sales by Application (2017-2022) & (Units)

Table 11. Global Bacille Calmette-Guerin Vaccine Sales Market Share by Application (2017-2022)

Table 12. Global Bacille Calmette-Guerin Vaccine Revenue by Application (2017-2022)

Table 13. Global Bacille Calmette-Guerin Vaccine Revenue Market Share by Application (2017-2022)

Table 14. Global Bacille Calmette-Guerin Vaccine Sale Price by Application (2017-2022) & (US$/Unit)

Table 15. Global Bacille Calmette-Guerin Vaccine Sales by Company (2020-2022) & (Units)

Table 16. Global Bacille Calmette-Guerin Vaccine Sales Market Share by Company (2020-2022)

Table 17. Global Bacille Calmette-Guerin Vaccine Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Bacille Calmette-Guerin Vaccine Revenue Market Share by Company (2020-2022)

Table 19. Global Bacille Calmette-Guerin Vaccine Sale Price by Company (2020-2022) & (US$/Unit)

Table 20. Key Manufacturers Bacille Calmette-Guerin Vaccine Producing Area Distribution and Sales Area

Table 21. Players Bacille Calmette-Guerin Vaccine Products Offered

Table 22. Bacille Calmette-Guerin Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Bacille Calmette-Guerin Vaccine Sales by Geographic Region (2017-2022) & (Units)

Table 26. Global Bacille Calmette-Guerin Vaccine Sales Market Share Geographic Region (2017-2022)

Table 27. Global Bacille Calmette-Guerin Vaccine Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Bacille Calmette-Guerin Vaccine Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Bacille Calmette-Guerin Vaccine Sales by Country/Region (2017-2022) & (Units)

Table 30. Global Bacille Calmette-Guerin Vaccine Sales Market Share by Country/Region (2017-2022)

Table 31. Global Bacille Calmette-Guerin Vaccine Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Bacille Calmette-Guerin Vaccine Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Bacille Calmette-Guerin Vaccine Sales by Country (2017-2022) & (Units)

Table 34. Americas Bacille Calmette-Guerin Vaccine Sales Market Share by Country (2017-2022)

Table 35. Americas Bacille Calmette-Guerin Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Bacille Calmette-Guerin Vaccine Revenue Market Share by Country (2017-2022)

Table 37. Americas Bacille Calmette-Guerin Vaccine Sales by Type (2017-2022) & (Units)

Table 38. Americas Bacille Calmette-Guerin Vaccine Sales Market Share by Type (2017-2022)

Table 39. Americas Bacille Calmette-Guerin Vaccine Sales by Application (2017-2022) & (Units)

Table 40. Americas Bacille Calmette-Guerin Vaccine Sales Market Share by Application (2017-2022)

Table 41. APAC Bacille Calmette-Guerin Vaccine Sales by Region (2017-2022) & (Units)

Table 42. APAC Bacille Calmette-Guerin Vaccine Sales Market Share by Region (2017-2022)

Table 43. APAC Bacille Calmette-Guerin Vaccine Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Bacille Calmette-Guerin Vaccine Revenue Market Share by Region (2017-2022)

Table 45. APAC Bacille Calmette-Guerin Vaccine Sales by Type (2017-2022) & (Units)

Table 46. APAC Bacille Calmette-Guerin Vaccine Sales Market Share by Type (2017-2022)

Table 47. APAC Bacille Calmette-Guerin Vaccine Sales by Application (2017-2022) & (Units)

Table 48. APAC Bacille Calmette-Guerin Vaccine Sales Market Share by Application (2017-2022)

Table 49. Europe Bacille Calmette-Guerin Vaccine Sales by Country (2017-2022) & (Units)

Table 50. Europe Bacille Calmette-Guerin Vaccine Sales Market Share by Country (2017-2022)

Table 51. Europe Bacille Calmette-Guerin Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Bacille Calmette-Guerin Vaccine Revenue Market Share by Country (2017-2022)

Table 53. Europe Bacille Calmette-Guerin Vaccine Sales by Type (2017-2022) & (Units)

Table 54. Europe Bacille Calmette-Guerin Vaccine Sales Market Share by Type (2017-2022)

Table 55. Europe Bacille Calmette-Guerin Vaccine Sales by Application (2017-2022) & (Units)

Table 56. Europe Bacille Calmette-Guerin Vaccine Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Bacille Calmette-Guerin Vaccine Sales by Country (2017-2022) & (Units)

Table 58. Middle East & Africa Bacille Calmette-Guerin Vaccine Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Bacille Calmette-Guerin Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Bacille Calmette-Guerin Vaccine Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Bacille Calmette-Guerin Vaccine Sales by Type (2017-2022) & (Units)

Table 62. Middle East & Africa Bacille Calmette-Guerin Vaccine Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Bacille Calmette-Guerin Vaccine Sales by Application (2017-2022) & (Units)

Table 64. Middle East & Africa Bacille Calmette-Guerin Vaccine Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Bacille Calmette-Guerin Vaccine

Table 66. Key Market Challenges & Risks of Bacille Calmette-Guerin Vaccine

Table 67. Key Industry Trends of Bacille Calmette-Guerin Vaccine

Table 68. Bacille Calmette-Guerin Vaccine Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Bacille Calmette-Guerin Vaccine Distributors List

Table 71. Bacille Calmette-Guerin Vaccine Customer List

Table 72. Global Bacille Calmette-Guerin Vaccine Sales Forecast by Region (2023-2028) & (Units)

Table 73. Global Bacille Calmette-Guerin Vaccine Sales Market Forecast by Region

Table 74. Global Bacille Calmette-Guerin Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Bacille Calmette-Guerin Vaccine Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Bacille Calmette-Guerin Vaccine Sales Forecast by Country (2023-2028) & (Units)

Table 77. Americas Bacille Calmette-Guerin Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Bacille Calmette-Guerin Vaccine Sales Forecast by Region (2023-2028) & (Units)

Table 79. APAC Bacille Calmette-Guerin Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Bacille Calmette-Guerin Vaccine Sales Forecast by Country (2023-2028) & (Units)

Table 81. Europe Bacille Calmette-Guerin Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Bacille Calmette-Guerin Vaccine Sales Forecast by Country (2023-2028) & (Units)

Table 83. Middle East & Africa Bacille Calmette-Guerin Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Bacille Calmette-Guerin Vaccine Sales Forecast by Type (2023-2028) & (Units)

Table 85. Global Bacille Calmette-Guerin Vaccine Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Bacille Calmette-Guerin Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Bacille Calmette-Guerin Vaccine Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Bacille Calmette-Guerin Vaccine Sales Forecast by Application (2023-2028) & (Units)

Table 89. Global Bacille Calmette-Guerin Vaccine Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Bacille Calmette-Guerin Vaccine Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Bacille Calmette-Guerin Vaccine Revenue Market Share Forecast by Application (2023-2028)

Table 92. Merck Basic Information, Bacille Calmette-Guerin Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 93. Merck Bacille Calmette-Guerin Vaccine Product Offered

Table 94. Merck Bacille Calmette-Guerin Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 95. Merck Main Business

Table 96. Merck Latest Developments

Table 97. Sanofi Pasteur Basic Information, Bacille Calmette-Guerin Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 98. Sanofi Pasteur Bacille Calmette-Guerin Vaccine Product Offered

Table 99. Sanofi Pasteur Bacille Calmette-Guerin Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 100. Sanofi Pasteur Main Business

Table 101. Sanofi Pasteur Latest Developments

Table 102. Japan BCG Lab Basic Information, Bacille Calmette-Guerin Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 103. Japan BCG Lab Bacille Calmette-Guerin Vaccine Product Offered

Table 104. Japan BCG Lab Bacille Calmette-Guerin Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 105. Japan BCG Lab Main Business

Table 106. Japan BCG Lab Latest Developments

Table 107. China National Biotec Basic Information, Bacille Calmette-Guerin Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 108. China National Biotec Bacille Calmette-Guerin Vaccine Product Offered

Table 109. China National Biotec Bacille Calmette-Guerin Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 110. China National Biotec Main Business

Table 111. China National Biotec Latest Developments

Table 112. Serum Institute of India Basic Information, Bacille Calmette-Guerin Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 113. Serum Institute of India Bacille Calmette-Guerin Vaccine Product Offered

Table 114. Serum Institute of India Bacille Calmette-Guerin Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 115. Serum Institute of India Main Business

Table 116. Serum Institute of India Latest Developments

Table 117. Intervax Basic Information, Bacille Calmette-Guerin Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 118. Intervax Bacille Calmette-Guerin Vaccine Product Offered

Table 119. Intervax Bacille Calmette-Guerin Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 120. Intervax Main Business

Table 121. Intervax Latest Developments

Table 122. GSBPL Basic Information, Bacille Calmette-Guerin Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 123. GSBPL Bacille Calmette-Guerin Vaccine Product Offered

Table 124. GSBPL Bacille Calmette-Guerin Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 125. GSBPL Main Business

Table 126. GSBPL Latest Developments

List of Figures

Figure 1. Picture of Bacille Calmette-Guerin Vaccine

Figure 2. Bacille Calmette-Guerin Vaccine Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Bacille Calmette-Guerin Vaccine Sales Growth Rate 2017-2028 (Units)

Figure 7. Global Bacille Calmette-Guerin Vaccine Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Bacille Calmette-Guerin Vaccine Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Immune

Figure 10. Product Picture of Therapy

Figure 11. Global Bacille Calmette-Guerin Vaccine Sales Market Share by Type in 2021

Figure 12. Global Bacille Calmette-Guerin Vaccine Revenue Market Share by Type (2017-2022)

Figure 13. Bacille Calmette-Guerin Vaccine Consumed in Private Distribution Channel

Figure 14. Global Bacille Calmette-Guerin Vaccine Market: Private Distribution Channel (2017-2022) & (Units)

Figure 15. Bacille Calmette-Guerin Vaccine Consumed in Public Distribution Channel

Figure 16. Global Bacille Calmette-Guerin Vaccine Market: Public Distribution Channel (2017-2022) & (Units)

Figure 17. Global Bacille Calmette-Guerin Vaccine Sales Market Share by Application (2017-2022)

Figure 18. Global Bacille Calmette-Guerin Vaccine Revenue Market Share by Application in 2021

Figure 19. Bacille Calmette-Guerin Vaccine Revenue Market by Company in 2021 ($ Million)

Figure 20. Global Bacille Calmette-Guerin Vaccine Revenue Market Share by Company in 2021

Figure 21. Global Bacille Calmette-Guerin Vaccine Sales Market Share by Geographic Region (2017-2022)

Figure 22. Global Bacille Calmette-Guerin Vaccine Revenue Market Share by Geographic Region in 2021

Figure 23. Global Bacille Calmette-Guerin Vaccine Sales Market Share by Region (2017-2022)

Figure 24. Global Bacille Calmette-Guerin Vaccine Revenue Market Share by Country/Region in 2021

Figure 25. Americas Bacille Calmette-Guerin Vaccine Sales 2017-2022 (Units)

Figure 26. Americas Bacille Calmette-Guerin Vaccine Revenue 2017-2022 ($ Millions)

Figure 27. APAC Bacille Calmette-Guerin Vaccine Sales 2017-2022 (Units)

Figure 28. APAC Bacille Calmette-Guerin Vaccine Revenue 2017-2022 ($ Millions)

Figure 29. Europe Bacille Calmette-Guerin Vaccine Sales 2017-2022 (Units)

Figure 30. Europe Bacille Calmette-Guerin Vaccine Revenue 2017-2022 ($ Millions)

Figure 31. Middle East & Africa Bacille Calmette-Guerin Vaccine Sales 2017-2022 (Units)

Figure 32. Middle East & Africa Bacille Calmette-Guerin Vaccine Revenue 2017-2022 ($ Millions)

Figure 33. Americas Bacille Calmette-Guerin Vaccine Sales Market Share by Country in 2021

Figure 34. Americas Bacille Calmette-Guerin Vaccine Revenue Market Share by Country in 2021

Figure 35. United States Bacille Calmette-Guerin Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 36. Canada Bacille Calmette-Guerin Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 37. Mexico Bacille Calmette-Guerin Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 38. Brazil Bacille Calmette-Guerin Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 39. APAC Bacille Calmette-Guerin Vaccine Sales Market Share by Region in 2021

Figure 40. APAC Bacille Calmette-Guerin Vaccine Revenue Market Share by Regions in 2021

Figure 41. China Bacille Calmette-Guerin Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 42. Japan Bacille Calmette-Guerin Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 43. South Korea Bacille Calmette-Guerin Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 44. Southeast Asia Bacille Calmette-Guerin Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 45. India Bacille Calmette-Guerin Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 46. Australia Bacille Calmette-Guerin Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 47. Europe Bacille Calmette-Guerin Vaccine Sales Market Share by Country in 2021

Figure 48. Europe Bacille Calmette-Guerin Vaccine Revenue Market Share by Country in 2021

Figure 49. Germany Bacille Calmette-Guerin Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 50. France Bacille Calmette-Guerin Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 51. UK Bacille Calmette-Guerin Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 52. Italy Bacille Calmette-Guerin Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 53. Russia Bacille Calmette-Guerin Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 54. Middle East & Africa Bacille Calmette-Guerin Vaccine Sales Market Share by Country in 2021

Figure 55. Middle East & Africa Bacille Calmette-Guerin Vaccine Revenue Market Share by Country in 2021

Figure 56. Egypt Bacille Calmette-Guerin Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 57. South Africa Bacille Calmette-Guerin Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 58. Israel Bacille Calmette-Guerin Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 59. Turkey Bacille Calmette-Guerin Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 60. GCC Country Bacille Calmette-Guerin Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 61. Manufacturing Cost Structure Analysis of Bacille Calmette-Guerin Vaccine in 2021

Figure 62. Manufacturing Process Analysis of Bacille Calmette-Guerin Vaccine

Figure 63. Industry Chain Structure of Bacille Calmette-Guerin Vaccine

Figure 64. Channels of Distribution

Figure 65. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Regenerative Medicine Market by Product Type (Cell Therapy, Gene Therapy, Tissue Engineering, and Small Molecule & Biologic), Material (Synthetic Material, Biologically Derived Material, Genetically Engineered Material, and Pharmaceutical), and Application (Cardiovascular, Oncology, Dermatology, Musculoskeletal, Wound Healing, Ophthalmology, Neurology, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...

  • Publish Date: May 29, 2018
  • $5370
World Medical Robotics and Computer - Assisted Surgery Market - Opportunities and Forecasts, 2015 - 2022

The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...

  • Publish Date: May 1, 2016
  • $5370